Historical record - last NADAC effective date: 4/22/2020
Product Information
RANITIDINE 15 MG/ML SYRUP is a generic product labeled by Pharmaceutical Associates, Inc., priced at $0.0579 per ML under NDC 00121072716. Its NADAC has been published 386 times since Nov 28, 2013.
FDA first approved this application on Sep 21, 2007.
Strength
15 mg/mL
Manufacturer
Pharmaceutical Associates, Inc.NDC
00121072716
Classification
Generic
Dosage Form
SYRUP
Route
ORAL
Effective Date
4/22/2020
Active Ingredients
RANITIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA077405FDA Approved
9/21/2007
On Market Since
11/1/2010
Pharmacological Classes
Price Statistics
The NADAC for RANITIDINE 15 MG/ML SYRUP has been published 386 times since Nov 28, 2013, and over the history we have for it it has risen 71.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0579 per ML |
|---|---|
| All-time high | $0.0831 (Nov 13, 2019) |
| All-time low | $0.0195 (Jan 23, 2019) |
| Median price | $0.0289 |
| Average price | $0.0355 |
| Largest weekly change | +126.9% (Jun 12, 2019) |
| Weeks tracked | 386 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+71.8%
Last surveyed Apr 14, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the RANITIDINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Pharmaceutical Associates, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
RANITIDINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RANITIDINE 15 MG/ML SYRUP?
The current National Average Drug Acquisition Cost (NADAC) for RANITIDINE 15 MG/ML SYRUP, manufactured by Pharmaceutical Associates, Inc., is $0.0579 per ML (NDC 00121072716), effective Apr 14, 2021.
How has the price of RANITIDINE 15 MG/ML SYRUP changed over time?
Over the history we have for it, the NADAC for RANITIDINE 15 MG/ML SYRUP has risen 71.8%. It has been tracked across 386 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RANITIDINE 15 MG/ML SYRUP?
Since Nov 28, 2013, the NADAC for RANITIDINE 15 MG/ML SYRUP has ranged from a low of $0.0195 (Jan 23, 2019) to a high of $0.0831 (Nov 13, 2019), with a median of $0.0289 per ML.
Are there cheaper alternatives to RANITIDINE 15 MG/ML SYRUP?
No other NADAC-published product currently shares the active ingredient and strength of RANITIDINE 15 MG/ML SYRUP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures RANITIDINE 15 MG/ML SYRUP?
RANITIDINE 15 MG/ML SYRUP (NDC 00121072716) is labeled by Pharmaceutical Associates, Inc., and CMS classifies it as a generic product.